Journal Article

QLIF-34. PILOT STUDY TO DESCRIBE THE TRAJECTORY OF SYMPTOMS AND ADAPTIVE STRATEGIES OF ADULTS LIVING WITH LOW GRADE GLIOMAS (LGG)

Mary Lou Affronti, Dina Randazzo, Katherine B Peters, Susan C Herndon, Patrick Healy, James E Herndon, Sarah Woodring, Karen Hawkins, Eric S Lipp, Olivia Kohrman, Annick Desjardins, Gordana Vlahovic, Henry S Friedman, Jung-Young Kim, Elizabeth S Miller and Susan Schneider

in Neuro-Oncology

Volume 19, issue suppl_6, pages vi208-vi209
Published in print November 2017 | ISSN: 1522-8517
Published online November 2017 | e-ISSN: 1523-5866 | DOI: https://dx.doi.org/10.1093/neuonc/nox168.843
QLIF-34. PILOT STUDY TO DESCRIBE THE TRAJECTORY OF SYMPTOMS AND ADAPTIVE STRATEGIES OF ADULTS LIVING WITH LOW GRADE GLIOMAS (LGG)

Show Summary Details

Preview

Abstract

BACKGROUND

Much attention is given to high-grade gliomas and the intense symptom burden on quality-of-life (QoL) but less is known about the adaptability to symptoms/challenges for patients with LGGs. Adaptive Leadership provides a novel conceptualization of symptom self-management for LGG patients as it promotes patient-centered, adaptive techniques/strategies for management of symptoms and resulting challenges to improve QoL.

OBJECTIVES

During the first 6 months post LGG diagnosis: Identify/describe patterns in symptoms/QoL measured by valid/reliable tools; Identify/describe through qualitative interviews patient/provider adaptive techniques/strategies; Describe relationships among patient characteristics (including biomarkers), symptoms/QoL, and adaptive techniques/strategies.

METHODS

Fifteen patients >18yrs, KPS≥70%, and ≤2-months post Grade II-LGG diagnosis were enrolled. FACT-G/Br/Cog, Beck-Depression-Inventory (BDI)-II, FACIT-fatigue, distress-scale were completed at 2, 4, and 6-months post-diagnosis. Qualitative interviews identifying symptoms/challenges and adaptive techniques/strategies were conducted to code themes at 4 and 6 months. Trajectory of change in symptoms/QOL was described using means and 95% confidence intervals.

RESULTS

Mean age=40, 27% male, 93% white, 40% KPS≥90%, 67% gross total resection; majority (67%) with frontal tumors. Pathology included diffuse astrocytoma/infiltrating glioma (60%) and oligodendroglioma (40%), 1p19q-codeletions (40%), IDH1mut (60%), and TERTmut (53%). Mean QoL scores at 2,4,6 months, respectively were FACT-Brain-Subscale (0-76):50,50,54; FACT-BR (0-184):126,126,130; FACT-Cog-impairment-subscale (0-72):50,49,46; BDI-II (0-63): 15.2,16.5,13.9; Distress (1-4):2.2,1.5,1.8. FACIT-Fatigue scores (0-52):31,32,35 suggest a clinically important decrease in fatigue (+/-3). Initial analyses suggest that patients with either IDH1mut, TERTmut consistently reported lower QoL and higher distress, depression, fatigue scores. Seizures were reported with IDH1mut (11%) but not IDH1wildtype. Lower QoL, depression, fatigue were seen with 1p19q-codeletions. Males reported higher QoL and lower depression/fatigue. Qualitative interview data will be presented identifying sustainable adaptive strategies in association with characteristics, symptoms and challenges.

CONCLUSIONS

1p19q-codeletions and IDH1/TERTmut may be related to lower QoL (from IDH1mut-related seizures). Future studies to explore 1p19q-codeletions/IDH1/TERTmut subtypes as predictors for QoL/adaptability to symptoms/challenges should be conducted.

Journal Article.  0 words. 

Subjects: Medical Oncology ; Neurology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.